Guiqiyang Xiang , Ping Zhu , Liuqingqing Zhang , Shuting Yu , Fangying Jiang , Shuai Wang , Jinzeng Wang , Yao Dai , Shengyue Wang , Yun Tan , Feng Liu
{"title":"RUNX1, SPI1和CEBPE的混合物有效诱导白血病到粒细胞","authors":"Guiqiyang Xiang , Ping Zhu , Liuqingqing Zhang , Shuting Yu , Fangying Jiang , Shuai Wang , Jinzeng Wang , Yao Dai , Shengyue Wang , Yun Tan , Feng Liu","doi":"10.1016/j.canlet.2025.217820","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":9506,"journal":{"name":"Cancer letters","volume":"626 ","pages":"Article 217820"},"PeriodicalIF":9.1000,"publicationDate":"2025-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Effective leukemia-to-granulocyte induction by a cocktail of RUNX1, SPI1 and CEBPE\",\"authors\":\"Guiqiyang Xiang , Ping Zhu , Liuqingqing Zhang , Shuting Yu , Fangying Jiang , Shuai Wang , Jinzeng Wang , Yao Dai , Shengyue Wang , Yun Tan , Feng Liu\",\"doi\":\"10.1016/j.canlet.2025.217820\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":9506,\"journal\":{\"name\":\"Cancer letters\",\"volume\":\"626 \",\"pages\":\"Article 217820\"},\"PeriodicalIF\":9.1000,\"publicationDate\":\"2025-05-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cancer letters\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0304383525003878\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer letters","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0304383525003878","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
期刊介绍:
Cancer Letters is a reputable international journal that serves as a platform for significant and original contributions in cancer research. The journal welcomes both full-length articles and Mini Reviews in the wide-ranging field of basic and translational oncology. Furthermore, it frequently presents Special Issues that shed light on current and topical areas in cancer research.
Cancer Letters is highly interested in various fundamental aspects that can cater to a diverse readership. These areas include the molecular genetics and cell biology of cancer, radiation biology, molecular pathology, hormones and cancer, viral oncology, metastasis, and chemoprevention. The journal actively focuses on experimental therapeutics, particularly the advancement of targeted therapies for personalized cancer medicine, such as metronomic chemotherapy.
By publishing groundbreaking research and promoting advancements in cancer treatments, Cancer Letters aims to actively contribute to the fight against cancer and the improvement of patient outcomes.